Androgen Receptor Structure and Function in Prostate Cancer

作者: Grant Buchanan , Wayne D. Tilley

DOI: 10.1007/978-1-4612-2092-3_32

关键词:

摘要: Androgens have diverse biological functions, playing a critical role during sexual development and in subsequent life to develop maintain male secondary sex tissues. Like the normal prostate, prostate cancers (PRCA) are initially dependent on androgens for their growth, androgen ablation or hormonal therapy remains major form of systemic treatment patients with metastatic disease. Although an initial response rate 70-80% is observed following initiation therapy, progression almost invariably occurs rapidly, less than 20% surviving 5 years (1). Nevertheless, precise mechanisms involved escape from androgenic control poorly characterized. Alterations one more determinants activity could contribute unresponsiveness conventional therapies: (a) cellular bioavailability potent metabolite testosterone, 5α- dihydrotestosterone (5α-DHT), (b) level structure receptor (AR), (c) expression profile specific cofactor molecules (Figure 1). This paper focuses AR function PRCA, particular emphasis contribution structural alterations failure therapies.

参考文章(24)
Wayne D. Tilley, David J. Horsfall, Villis R. Marshall, James O. Aspinall, Sylvia S. Lim-Tio, John M. Skinner, Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Research. ,vol. 54, pp. 4096- 4102 ,(1994)
Cor W. Kuil, Cor A. Berrevoets, Eppo Mulder, Ligand-induced Conformational Alterations of the Androgen Receptor Analyzed by Limited Trypsinization STUDIES ON THE MECHANISM OF ANTIANDROGEN ACTION Journal of Biological Chemistry. ,vol. 270, pp. 27569- 27576 ,(1995) , 10.1074/JBC.270.46.27569
Shawn P. Williams, Paul B. Sigler, Atomic structure of progesterone complexed with its receptor. Nature. ,vol. 393, pp. 392- 396 ,(1998) , 10.1038/30775
A. Mahfoudi, E. Roulet, S. Dauvois, M. G. Parker, W. Wahli, Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 4206- 4210 ,(1995) , 10.1073/PNAS.92.10.4206
Z Culig, A Hobisch, M V Cronauer, A C Cato, A Hittmair, C Radmayr, J Eberle, G Bartsch, H Klocker, Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Molecular Endocrinology. ,vol. 7, pp. 1541- 1550 ,(1993) , 10.1210/MEND.7.12.8145761
J P Elo, L Kvist, K Leinonen, V Isomaa, P Henttu, O Lukkarinen, P Vihko, Mutated Human Androgen Receptor Gene Detected in a Prostatic Cancer Patient Is Also Activated by Estradiol The Journal of Clinical Endocrinology and Metabolism. ,vol. 80, pp. 3494- 3500 ,(1995) , 10.1210/JCEM.80.12.8530589
Zoran Culig, Alfred Hobisch, Anton Hittmair, Heike Peterziel, Andrew C.B. Cato, Georg Bartsch, Helmut Klocker, Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. The Prostate. ,vol. 35, pp. 63- 70 ,(1998) , 10.1002/(SICI)1097-0045(19980401)35:1<63::AID-PROS9>3.0.CO;2-I
Hiroyoshi Suzuki, Naohide Sato, Yoshio Watabe, Motoyuki Masai, Susumu Seino, Jun Shimazaki, Androgen receptor gene mutations in human prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 46, pp. 759- 765 ,(1993) , 10.1016/0960-0760(93)90316-O
Sarah L Anzick, Juha Kononen, Robert L Walker, David O Azorsa, Minna M Tanner, Xin-Yuan Guan, Guido Sauter, Olli-P Kallioniemi, Jeffrey M Trent, Paul S Meltzer, AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer Science. ,vol. 277, pp. 965- 968 ,(1997) , 10.1126/SCIENCE.277.5328.965